3655 NOBEL DRIVE, SAN DIEGO, CA
Unregistered Sales of Equity Securities
Investor Presentation
News, Underwriting Agreement, Articles of Incorporation, Securities Holder Rights or Indentures, Material Contracts
Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization
Financial Results, Press Release
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
QUALIF
Regulation A Offering Circular Supplement (Annual Report)
Offering Statement - Qualified Offering Circular
Regulation A Offering Circular Supplement
Amended Offering Statement
Offering Statement